We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Unveils Action Plan for Artificial Intelligence/Machine Learning Software
FDA Unveils Action Plan for Artificial Intelligence/Machine Learning Software
The FDA has released a new action plan that outlines a potential approach to premarket reviews for artificial intelligence (AI) and machine learning-(ML) software modifications.
To View This Article:
Login
Subscribe To International Devices & Diagnostics Monitor